Recombinant Chimpanzee DEFB106A Protein ，His & KSI

DEFB106A, a member of the defensin family of antimicrobial peptides, has garnered significant attention due to its potential roles in innate immunity and its involvement in various physiological and pathological processes. This protein is predominantly expressed in human epithelial tissues, particularly in the respiratory and reproductive tracts, where it plays a crucial role in host defense against a wide range of pathogens, including bacteria and viruses. Research into DEFB106A has increased as studies reveal its ability to modulate inflammatory responses, contribute to wound healing, and maintain microbial homeostasis. Additionally, its association with conditions such as allergies, asthma, and certain types of cancer highlights its importance in health and disease. The recombinant expression of DEFB106A facilitates detailed investigations into its structural and functional properties, enabling scientists to explore its therapeutic potential. By using techniques such as recombinant DNA technology, researchers can produce DEFB106A in sufficient quantities for functional assays, antibody production, and further studies into its mechanism of action. Understanding DEFB106A’s interactions at the molecular level is essential for developing novel strategies for disease treatment and prevention, making it a subject of growing interest in immunology and biomedicine.